Veterinary Medicines

Biocan DHPPi+L vakcina A.U.V.

Authorised
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
  • Canine distemper virus, Live
  • Canine adenovirus 2, Live
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Live
Download as PDF

Product identification

Medicine name:
Biocan DHPPi+L vakcina A.U.V.
Active substance:
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
  • Canine distemper virus, Live
  • Canine adenovirus 2, Live
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
    5.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine distemper virus, Live
    3.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine adenovirus 2, Live
    3.50
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine parvovirus, Live
    4.50
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine parainfluenza virus, Live
    3.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alpha-Vet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • NEBIH
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."